included in the PK, safety, and ITT populations. The mean age of patients was 5.3 years (range, 2-12), half were females, and most were white (33/34 [97.1%]) and non-Hispanic/Latino (29/34 [85.3%]) (Table 1). The mean number of MC lesions at baseline was 50.2 (median, 35.0; range, 21-212).
Treatment Compliance
During the PK period, patients/caregivers were highly (97.7%) compliant with treatment application.
Pharmacokinetic Parameters
No patients had quantifiable plasma hMPA3 concentrations at any timepoint on day 1, and 2 patients had quantifiable
